ANNUAL REPORT JULY 2017-2018

IN REMEMBERANCE OF DAVID COOPER

David was internationally recognized as a leading HIV clinician and clinical investigator. He passed away on 18 March 2018, surrounded by his family at St Vincent’s Hospital in Sydney, Australia, at the age of 68 after a short illness.

Since diagnosing some of Australia’s first cases of HIV in 1983, he dedicated his career to HIV epidemiology, treatment and prevention. Helping those most vulnerable was at the core of his life's work, leading studies on HIV prevention and therapeutic strategies in low- and middle-income countries.

David was the Inaugural Director of the Kirby Institute for Infection and Immunity in Society, established in 1986. The Kirby Institute has long been the pillar of HIV and AIDS epidemiology, surveillance and research in Australia. As the head of the Institute, David worked with HIV clinicians and researchers around the world, but perhaps nowhere as closely as in Asia. Under his direction, the Kirby Institute developed collaborative programmes in several countries across the Asia-Pacific region.

Under his leadership, the programmes involved training healthcare workers and health researchers, and advising governments on public health and clinical policy to increase access to essential medicines.

In 1996, he co-founded HIV-NAT, a clinical research and trials collaboration based at the Thai Red Cross AIDS Research Centre at the Chulalongkorn University Hospital in Bangkok, Thailand. He authored more than 800 published scientific papers and served on editorial boards of several international journals.

During his tenure as IAS President, he led the International AIDS Conference in Vancouver, Canada (AIDS 1996). That conference, which presented the introduction of combination therapy, served as a turning point in the history of AIDS.

ABOUT THE IAS

Mission

The mission of the International AIDS Society (IAS) is to lead collective action on every front of the global HIV response through its membership base, scientific authority and convening power.

How we do it

Science. The IAS pursues and supports scientific advancements that positively alter the course of the HIV epidemic and promote greater understanding of these discoveries. The IAS pushes for the full spectrum of scientific achievement – from basic science to implementation research – and uses the visibility of its meetings to highlight dynamic, innovative work.

People. The IAS invests in professionalizing and promoting the HIV workforce – particularly the next generation of HIV professionals – to build the skills and resources that are needed to end the epidemic. As a membership body, the IAS understands and represents the interests of its members in all of its work, retaining a global perspective that is relevant at a local level.

Progress. The IAS uses its scientific authority to move science into policy and policy into tangible impact against the epidemic. The IAS advocates for sustained global leadership and increased investment while keeping the fight against stigma and discrimination at the heart of its work.

For more information, read the IAS 2016-2020 organizational strategy.

MEMBERSHIP

The IAS is the world’s largest association of HIV professionals, with members from more than 160 countries working on all fronts of the global response. Together, we advocate and drive urgent action to reduce the global impact of HIV.

Between July 2017 and July 2018, the IAS membership base reached 11,067 individuals. IAS Members include researchers, clinicians, service providers, policy makers, people living with HIV and community advocates.

Capacity building

HIV science evolves rapidly, requiring constant interpretation, translation and knowledge exchange. The IAS is committed to promoting greater understanding of HIV science and policy in order to build the skills and resources that are needed to end the epidemic – retaining a global perspective that is relevant at a local level.

As part of this commitment, the IAS published the IAS 2017 Knowledge Toolkits. This is the second edition of the knowledge toolkits series developed exclusively for IAS Members, highlighting important scientific advancements and innovative research presented at IAS and International AIDS conferences. The toolkit series offers adaptable PowerPoint presentations with an easy navigation system and printable speaker notes covering the four scientific tracks presented at IAS 2017 in Paris, France.

This series will continue with the AIDS 2018 Knowledge Toolkits, which will provide more research and tools for IAS Members. For open-access toolkits from AIDS 2016, visit the knowledge toolkits archive.

Learn how to access these toolkits and other exclusive IAS Member benefits here: https://www.iasociety.org/Membership/Become-a-Member/Benefits

IAS General Members’ Meeting

To build a strong, informed and connected IAS membership body, the IAS convenes the annual IAS General Members’ Meeting.

On 26 July 2017, the IAS General Members’ Meeting took place during IAS 2017 in Paris. More than 200 IAS Members attended the meeting, which was chaired by IAS President Linda-Gail Bekker. The meeting can be viewed in English, and with subtitles in French, Spanish and Portuguese.

#IASONEVOICE

The #IASONEVOICE membership campaign continued for the third year, highlighting the key topics most important to IAS Members, sharing their personal perspectives from working and volunteering on all fronts of the HIV response. This year, the campaign featured the following stories and opinions:

Getting to GIPA 2.0
When HIV is criminalized
Women in science
Patients versus patents
What do the SDGs mean to me?
Our own best advocates

For more stories visit: www.iasociety.org/Membership/IASONEVOICE/Stories

IAS membership at a glance

The following graphics provide a breakdown of IAS membership from this calendar year.

IAS EDUCATIONAL FUND

Translating the science and capacity building

The IAS Educational Fund was established in 2016 to provide educational and training opportunities to frontline HIV professionals.

In 2018, the IAS Educational Fund launched a new initiative, the Mark Wainberg Fellowship Programme. It is aimed at contributing to improving the quality of HIV service delivery in resource-limited settings by providing two-year fellowships to clinicians from sub-Saharan Africa, who will spend one year in Europe and one year in Africa at clinical institutions. The programme offers in-depth training for clinicians committed to careers in HIV clinical service delivery in sub-Saharan Africa with the aim of strengthening access to high-quality services for populations in the region using a client-centred service delivery approach.

2018 Scholarships

The IAS Educational Fund granted awards to 146 clinicians and HIV service providers from 48 countries to attend AIDS 2018.

Regional meetings

BUENOS AIRES, ARGENTINA / 3-4 NOVEMBER 2017
Challenges for PrEP implementation in Argentina

This workshop was organized in collaboration with Fundación Huésped and in conjunction with the workshop on Comprehensive Management of Aging in HIV-Infected Subjects on 2-3 November 2017. IAS Governing Council member Horacio Salomon co-chaired the meeting. The first of its kind in Argentina, the meeting brought together leading HIV scientists and community representatives to discuss the implementation and relevance of PrEP in Argentina. The meeting was held in Spanish.

BANGKOK, THAILAND / 16 NOVEMBER 2017
Science and Community in the Response to HIV, STIs and Co-infections in Asia and the Pacific

This workshop was organized in collaboration with the APCOM Foundation and in conjunction with the RRRAP Summit on 13-17 November 2017. IAS Executive Committee member Adeeba Kamarulzaman co-chaired the meeting. With IAS Governing Council member Roy Chan and more than 50 HIV scientists and community representatives from throughout the Asia and the Pacific region, topics such as PrEP and STIs, as well as the role of community-based organizations in the response to STIs, HIV and HCV, were discussed.

ABIDJAN, CÔTE D’IVOIRE / 3-4 DECEMBER 2017
A Scientific Response to HIV in West and Central Africa: Translating Best Practice into Policy and Implementation

This series of meetings was organized in collaboration with the African Network for AIDS Physicians and Practitioners and in conjunction with the 19th International Conference on AIDS and STIs in Africa (ICASA 2017) on 4-9 December 2017. IAS Governing Council member Serge Eholié led the meeting. The scientific symposium on 4 December was attended by more than 120 HIV scientists and community representatives from West and Central Africa. It was chaired by IAS Executive Committee member Alex Muganga Muganzi and entitled “Linkages between recommendations and operational implementation – Lessons learned with HIV”. The meetings were held in French.

BEIRUT, LEBANON / 25-26 JANUARY 2018
HIV, Human Rights and Sustainability: From Analysis to Action

This was the third in a series of meetings on HIV in conservative social settings with a focus on scaling up effective prevention, treatment and care services for key and priority populations. The meeting was organized in collaboration with the Global Institute for Health and Human Rights at the State University of New York at Albany and the American University of Beirut. It brought together 65 participants from Islamic-majority countries in the Middle East and North Africa, East Africa and Eastern Europe and Central Asia regions. IAS Immediate Past President Chris Beyrer co-chaired the meeting.

MEXICO CITY, MEXICO / 17, 18, 21 APRIL 2018
Translating Science to End HIV in Latin America and the Caribbean

This series of meetings took place in conjunction with the HIV & Hepatitis in the Americas congress on 19-21 April 2018. IAS President-Elect Anton Pozniak and IAS Governing Council members Luis Soto-Ramirez, Mauro Schechter and Kenneth Mayer co-chaired the meeting. The meeting brought together 148 participants from the Latin American and Caribbean region. It was held in Spanish and English.

TOKYO, JAPAN / 24 APRIL 2018
Ending AIDS by 2030: Science, Community and Political Commitment

This meeting was organized in collaboration with the Japan Center for International Exchange/Friends of the Global Fund, Japan, and coincided with the inaugural visit of the Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria to Japan. With leading scientists, policy makers, advocates and funders in the HIV response, the state of the HIV epidemic in Japan and globally was discussed from a scientific, policy and human rights perspective. IAS Executive Committee member Adeeba Kamarulzaman and IAS Governing Council member Shuzo Matsushita presented during the meeting. It was held in Japanese and English.

CHENNAI, INDIA / 28-29 APRIL 2018
Translating the science to end new HIV infections in Kenya – Perspectives, practices and lessons

This scientific symposium and meeting of experts and implementers were organized in collaboration with YR Gaitonde Centre for AIDS Research and Education and took place within the framework of the Chennai ART Symposium (CART 2018) on 28-29 April 2018. IAS Executive Committee member Kenneth Mayer co-chaired and presented in two meetings that brought together over 250 participants.

KYIV, UKRAINE / 30 MAY 2018
HIV in Eastern Europe and Central Asia: Regional achievements and challenges

This IAS Educational Fund meeting was co-chaired by IAS Governing Council member Sergii Dvoriak. Over 40 HIV scientists and community representatives from Eastern Europe and Central Asia discussed HIV, TB and hepatitis in people who inject drugs; community based research; as well as HIV and youth and adolescents. The meeting was carried it out in Russian and English.

HIV PROGRAMMES AND ADVOCACY

The IAS HIV Programmes and Advocacy department works to promote the implementation of evidence-informed and human rights-based strategies for improving the lives of people living with and most vulnerable to acquiring HIV.

Through its various programmes, the department harnesses research, shapes the evidence base and amplifies the voices of communities living with and affected by HIV to influence policy across and beyond the HIV prevention to care continuum. To do this, the department undertakes advocacy, supports capacity building and engages in collaborative partnerships with a range of organizations, including civil society and communities around the world.

The department’s HIV Programmes and Advocacy operational strategy for 2017-2020 instigates action across three linked domains: policy, research and structural barriers.

Policy

Influence global and national HIV policy and bridge gaps between the HIV response and the broader integrated health landscape.

Research

Inspire HIV research targeting scientific gaps in strategic priority areas.

Structural barriers

Instigate action to remove structural barriers and address human rights violations that prohibit access to and uptake of comprehensive HIV services for selected. populations and communities.

Across its broad platform of work, the IAS HIV Programmes and Advocacy department maintains a focus on three cross-cutting issues: human rights, gender and youth. Each of the department’s programmes is intended to purposely incorporate and mainstream these issues into its activities.

Our portfolio


Collaborative Initiative for Paediatric HIV Education and Research (CIPHER)

The year under review marked five years since the launch of CIPHER. Since then, CIPHER has been committed to place the unique challenges that infants, children and adolescents living with and affected by HIV face firmly on the global public health agenda.

Guided by a world-class Scientific Technical and Advisory Committee (STAC) of experts in paediatric HIV, CIPHER works to: 1) promote and invest in targeted research to address priority knowledge gaps in paediatric HIV; 2) convene stakeholders and establish collaboration mechanisms to strengthen communication, knowledge transfer and exchange among paediatric HIV cohorts; and 3) advocate to support evidence-informed clinical, policy and programmatic decision making.

Featured work - Policy

The CIPHER Cohort Collaboration worked with the UNAIDS Reference Group on Estimates, Modelling and Projections to improve the model for the 2017 UNAIDS estimates for the number of children living with HIV globally. The data on young children provided by the collaboration improved the distribution by age of those children starting on ART.


Differentiated Service Delivery

Current models of providing HIV services for prevention, testing, care and treatment are being stretched to the limit. Innovative and client-centred approaches are needed to meet the diverse needs and expectations of all people living with HIV. The IAS Differentiated Service Delivery initiative, previously known as the Differentiated Care initiative, is committed to increasing the scale-up of differentiated service delivery (DSD) and improving access to quality prevention and treatment services for people living with and vulnerable to HIV, including key populations and young people.

The initiative works collaboratively to support implementation and catalyze community advocacy that amplifies global best practices, tools and evidence to effectively reach the 37 million people worldwide in need of high-quality, life-saving HIV care.

Featured work - Structural barriers

The initiative partnered with the International Treatment Preparedness Coalition (ITPC) and AIDS and Rights Alliance for Southern Africa (ARASA) to initiate a series of efforts to support demand creation and community mobilization, including the development of “What works for me: Activist toolkit on differentiated service delivery”. The toolkit is available here.


HIV Co-Infections and Co-Morbidities

With increased access to antiretroviral therapy and improved monitoring of treatment effectiveness in much of the world, fewer people are dying from AIDS-related causes, and those with HIV are living longer than ever before. However, while the number of AIDS-related deaths has decreased since its peak in 2005, too many people continue to die from AIDS-related illnesses each year.

Among people living with HIV, morbidity and mortality is increasingly driven by co-infection with other diseases, including hepatitis C (HCV) and tuberculosis, and co-morbidity with non-communicable diseases. The IAS HIV Co-Infections and Co-Morbidities initiative focuses on a number of areas, including service delivery needs of people living with HIV and co-infections and/or related co-morbidities.

Featured work - Structural barriers

The initiative advocated for prioritizing people who inject drugs (PWID) in HCV elimination efforts. A commentary, published in the Journal of the International AIDS Society (JIAS) on World Hepatitis Day, discusses why PWID should be considered as a priority population in these efforts. It details the reasons why this goal could be attainable among PWID, the challenges that must be overcome and key recommendations for action. The paper is available here.


Industry Liaison Forum (ILF)

The past decade has been marked by rapid advances in HIV research, leading to the introduction of more advanced and client-friendly technologies for diagnosing and treating people living with HIV and preventing transmission. Critical gaps remain across the continuum from research and development to manufacturing, delivery and uptake of medical innovations to the people who most need them across the HIV cascade.

The IAS ILF works to promote and facilitate the full contribution of the biomedical industry to the global HIV response by catalysing open dialogue, meaningful engagement and collaborative action to address barriers along the HIV care continuum. It focuses on two main areas: paediatric HIV (to fast track the development of paediatric HIV medicines, and focusing on the most-needed paediatric ARV formulations); and regulatory affairs (to improve regulatory approval processes for timely access to quality HIV diagnostics and medicines by populations most in need).

Featured work - Research

The ILF worked with a large group of stakeholders, including CIPHER, to develop the Global Accelerator for Paediatric Formulations (GAP-f). A commentary published in JIAS describes the GAP-f as an innovative collaborative model that will accelerate availability of optimized treatment options for infectious diseases, such as HIV, tuberculosis and viral hepatitis, affecting children in low- and middle-income countries. The paper is available here.


Journal of the International AIDS Society (JIAS)

JIAS is a peer-reviewed and PubMed- and Medline-indexed journal that publishes the latest HIV research online and free of charge to readers. As a multidisciplinary journal, it generates and disseminates impactful evidence on a variety of topics from social, behavioural, political and economic research to biomedical and clinical research, while leading the way in implementation and operational research.

In addition to publishing special thematic supplements, the JIAS invests in strengthening the capacity and empowerment of early-career researchers from low- and middle-income countries to ensure that their research has an enlarged platform.

Featured work - Research

The journal published the special issue, “Toward the global viral hepatitis elimination for all patients in all income settings”, to contribute to the development of a public health approach that will assure access to antiviral therapy for all co-infected patients. The special issue is available here.


Nobody Left Behind

Key populations – men who have sex with men, transgender people, sex workers and people who inject drugs – are at the centre of the global fight against HIV. Yet few programmes shine a spotlight on these groups, resulting in low coverage of HIV prevention interventions and higher rates of HIV acquisition and HIV prevalence.

The Nobody Left Behind initiative gives prominence to the challenges faced by key populations and works towards removing barriers affecting their access to HIV prevention, treatment and care services.

Featured work - Policy

At IAS 2017, the Nobody Left Behind initiative hosted an invite-only meeting on the topic, “Are we doing enough to reduce HIV-related stigma and discrimination towards key populations?” The informal discussion brought together 30 policy and community representatives to discuss the persistent challenges in healthcare settings and provided a unique opportunity to discuss best practices for key populations.


Towards an HIV Cure

The toolbox of interventions in the HIV response has dramatically expanded since the discovery of the virus. A cure has remained beyond our grasp, but research to develop a cure for HIV or long-term remission has made promising progress, spurring renewed excitement in the field among researchers, advocates and community members alike.

To that end, the mission of the Towards an HIV Cure initiative is to drive concerted efforts to accelerate global scientific research and engagement towards a cure for HIV.

Featured work - Research

The initiative convened specialists in the HIV and oncology research fields at the HIV Cure & Cancer Forum to foster an exchange of ideas. While the scientific community remains cautious, data presented at the forum highlighted the fact that a synergistic approach will prove to be beneficial to both disciplines. Information and resources from the forum are available here.


Adolescent HIV Treatment Coalition (ATC)

Hosted by the IAS, the ATC is made up of a diverse group of stakeholders in the HIV response united to advocate for quality treatment and care for all adolescents living with HIV. The ATC is governed by a steering committee of youth-focused organizations and provides a collective voice promoting accountability in the HIV response to the realities of adolescent lives. As part of its advocacy portfolio, it calls attention to gaps, proposes solutions and works collaboratively on a range of adolescent treatment issues.

Featured work - Structural barriers

The ATC published a commentary in CIPHER’s special JIAS issue, “Paediatric and Adolescent HIV and the Sustainable Development Goals: the road ahead to 2030”. The commentary, titled “Ending AIDS by 2030: the importance of an interlinked approach and meaningful youth leadership”, calls for action to improve advocacy and service delivery for young people by leveraging the interlinkages between HIV and the broader development agenda. The commentary is available here.

Our campaigns

Me and My Healthcare Provider

The IAS Me and My Healthcare Provider campaign, part of the Nobody Left Behind initiative, puts a spotlight on the frontline healthcare providers who address the HIV-related needs of key populations, often in the face of discriminatory laws, traditions and belief systems.

The campaign is driven by members of key populations – men who have sex with men, transgender people, people who inject drugs and sex workers – who nominate their healthcare providers for #DoingTheRightThing and making a tangible difference in their lives. In 2017, three healthcare providers (from Kenya, Indonesia and Botswana) were recognized at the plenary session of IAS 2017 by United States Ambassador Birx. Their stories were highlighted on the IAS website and were presented as an interactive resource at the thematic session, “Actions to reduce stigma and discrimination in all its forms”, during the 2017 UNAIDS Programme Coordinating Board meeting. Their stories are available here.

Youth Voices Campaign

IAS Youth Voices is an advocacy campaign that supports the active participation of adolescents in the HIV response through focus groups, educational opportunities, financial support, tailored resources and amplifying personal stories to help shape key policy decisions.

The campaign focuses on expanding youth leadership across a range of community-based organizations through a “Youth Champion” seed grant programme on key priority topics, shaping collective advocacy through films and policy briefs to highlight young people’s contributions to and needs in the HIV response, and strengthening capacity and providing networking opportunities to young people at international meetings and conferences.

From March 2018 until August 2019, the Youth Voices campaign is working with five organizations in sub-Saharan Africa to support young people to strengthen youth-friendly HIV service delivery in their communities and to disseminate their stories, experiences and advocacy materials. All stories and materials are available here.

In development

Generation Now

The IAS and Women Deliver Generation Now partnership came together in response to building momentum to link national and global efforts to end the HIV epidemic and protect sexual and reproductive health and rights (SRHR). Ensuring universal access to sexual and reproductive health services, achieving gender equality and empowering especially adolescent girls and young women to exercise their sexual and reproductive rights are critical for an effective HIV response. Yet HIV and SRHR responses are still often placed in silos.

Generation Now is aimed at uniting policy makers, implementers and advocates to increase understanding of and advocate for linked HIV and SRHR policies and systems and to better integrate services.

Vaccine Programme

In September 2017, the Global HIV Vaccine Enterprise announced a partnership with the IAS to host its operations. The IAS will help expand the impact of the enterprise’s HIV vaccine initiatives through its global network of HIV professionals, adopting a synergistic approach with the many stakeholders in the HIV vaccine space and adding value through its convening role.

The IAS started developing a five-year strategy for the new Vaccine Programme within the context of scientific advancements and developments in the field. This represents an important opportunity to streamline and strengthen the work of the enterprise and explore a meaningful programmatic role for the IAS that is highly responsive to a rapidly evolving HIV vaccine research environment.

Learn more about the HIV Programmes and Advocacy portfolio here: www.iasociety.org/HIV-Programmes

9TH IAS CONFERENCE ON HIV SCIENCE

On 23-26 July 2017, 6,277 HIV professionals and community members from around the world gathered in Paris, France, for the 9th IAS Conference on HIV Science (IAS 2017).

Hosting IAS 2017 in Paris is significant: the city has a long and impressive history in demonstrating leadership in HIV science, including co-discovery of the virus. This was the fourth time that Paris hosted a major international HIV and AIDS conference, further demonstrating France’s leadership and commitment to science research and optimizing HIV care and prevention.

Today, more people are on treatment than ever before. AIDS-related deaths have dropped by more than 50% since 2015. Yet the urgent need to scale up HIV prevention and treatment in many countries and populations remains, and the role of science in making this happen underscored the conference. As noted in the IAS 2017 Paris Statement and echoed throughout the event, “We cannot achieve ambitious global goals to provide life-long treatment to the 37 million people living with HIV and reduce the epidemic without an unfaltering commitment to research.”

The IAS organized the four-day conference in partnership with the French National Agency for Research on AIDS and Viral Hepatitis (ANRS). IAS 2017 prioritized basic science, a prerequisite step to ending the HIV epidemic, and highlighted a broad and diverse range of HIV research, including HIV cure and associated co-infections, such as viral hepatitis and tuberculosis. The meeting also featured studies that shine a light on the specific needs of key and priority populations, including transgender people, men who have sex with men, sex workers, people who inject drugs and young people.

By the numbers

By the headlines

“Scientists Report a Rare Case of H.I.V. Remission”

“Injections ‘Next Revolution’ In HIV – Study”

“Swaziland Makes Major Strides Against Its AIDS Epidemic”

“Ipergay Trial: PrEP Still Protected People Who Had Less Sex and Used It Less Often”
 

For more information on the scientific highlights, speakers and the overall evaluation of IAS 2017, read the full conference report here.

GOVERNANCE

IAS Governing Council

The IAS Governing Council is the executive body of the IAS. It approves the annual budget and presents financial and other information to the IAS General Members’ Meeting at each International AIDS Conference and each IAS Conference on HIV Science.

From left to right:
President, Linda-Gail Bekker
President-Elect, Anton Pozniak
Treasurer, Celia DC Christie-Samuels
Immediate Past President, Chris Beyrer
Executive Director, Owen Ryan

Regional Representatives on the IAS Governing Council

AFRICA
Alex Muganga Muganzi - Regional Representative
Serge Paul Ehoilé
James G Hakim
Kenneth Ngure
EUROPE
Jürgen Rockstroh - Regional Representative
Sergii Dvoriak
Bruno Spire
Stefano Vella
ASIA AND THE PACIFIC ISLANDS
Adeeba Kamarulzaman - Regional Representative
Roy Chan
Sharon Lewin
Shuzo Matsushita
LATIN AMERICA AND THE CARIBBEAN
Luis Soto-Ramirez - Regional Representative
Russell Pierre
Horacio Salomon
Mauro Schechter
UNITED STATES AND CANADA
Kenneth Mayer - Regional Representative
Adaora Adimora
Judith Auerbach
Marina Klein
 

IAS Executive Committee

The IAS Executive Committee acts on behalf of the IAS Governing Council and provides effective oversight and review of the IAS’s operations and finances between Governing Council meetings. The committee also reviews and appraises the performance of the IAS Executive Director.

The Executive Committee consists of the President, President-Elect, Treasurer and one regional representative selected from the Governing Council members of each region, as well as the Executive Director as a non-voting member. The President may also invite other Governing Council members to Executive Committee meetings to participate in discussions of matters within their area of expertise.

FINANCIAL REPORTS

SUPPORTERS

Thank you to our July 2017-June 2018 supporters

We would like to thank our dedicated supporters, without whom we could not realize the impact of our work.

Abbott Molecular
AbbVie
Agence de recherche ANRS (France Recherche Nord & Sud Sida-HIV Hépatites)
Alere
amfAR
Beckman Coulter
Bill & Melinda Gates Foundation
Biocentric
Cepheid
Chevron
Cipla
Coral Healthcare
European AIDS Clinical Society
Female Health Company
Ford Foundation
Gilead Sciences
Hetero Labs
Hologic
Institut Curie

Janssen Pharmaceutical
Lupin
Merck Sharp & Dohme
Mylan
The Netherlands - Ministry of Foreign Affairs
Omega Diagnostics
OPEC Fund for International Development
Pharco Pharmaceuticals
Prevention Access Campaign
Roche
Sidaction
SmartGene
Sysmex Partec
UNITAID
U.S. Department of Health and Human Services
U.S. National Institute of Allergy and Infectious Diseases
U.S. National Institute on Drug Abuse
ViiV Healthcare
WHO

JOIN US

Become an IAS Member
Join the collective voice of policy makers, researchers, scientists and community members to shape the global HIV response. Visit www.iasociety.org/membership to learn more about our work and the benefits of becoming a member.

Stay up to date
Join the IAS mailing list to receive the latest news, updates and announcements.

Spread the word and join the conversation
Follow us on social media to help amplify the work of the HIV response.

Like us on Facebook: www.facebook.com/IASociety
Follow us on Instagram: @IASociety
Follow our LinkedIn profile: www.linkedin.com/company/international-aids-society
Follow us on Twitter: @IASociety
Subscribe to our YouTube channel: www.youtube.com/channel/UC43XbxjX7RZZ_gK9Vt8Z8FA

Download the full report here